Condition: Alveolar Soft Part Sarcoma · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
This is a Phase II, single-arm, multicenter clinical study aimed at demonstrating the effectiveness of benmelstobart injection combined with anlotinib hydrochloride capsules in patients aged 14 years or older with advanced or unresectable alveolar soft part sarcoma by evaluating the objective response rate (IRC).
This description comes directly from the study's public registry record.
Jiayong Liu, Doctor · 13641103227 · liujiayong@aliyun.com
Jing Chen, Doctor · 15807183251 · chenjingunion@163.com
Always discuss trial participation with your own doctor first.
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Army Medical University of the People's Liberation Army of China | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Sun Yat-sen University Cancer Center | Guangdong, Guangdong, China | Not Yet Recruiting |
| Harbin Medical University Cancer Hospital | Harbin, Heilongjiang, China | Not Yet Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Not Yet Recruiting |
| Xiangya Hospital of Central South University | Changsha, Hunan, China | Not Yet Recruiting |
| The first hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
| Shandong First Medical University Affiliated Tumor Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Shanghai General Hospital | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
| West China Hospital of Sichuan University | Chengdu, Sichuan, China | Not Yet Recruiting |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin, Tianjin Municipality, China | Not Yet Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07548177